An interventional study of Ciprofol and Remimazolam in Colorectal Diseases Undergoing Elective Laparoscopic Colorectal Surgery, sponsored by The First Affiliated Hospital of Zhengzhou University. Completed at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by The First Affiliated Hospital of Zhengzhou University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a single-center, prospective, parallel randomized controlled trial. A total of 180 patients aged 18-75 years undergoing elective laparoscopic colorectal surgery with ASA physical status Ⅰ-Ⅲ will be enrolled and randomly assigned in a 1:1:1 ratio to ciprofol group, remimazolam group or propofol group. All patients receive standardized background anesthesia regimen including dexmedetomidine, sufentanil, rocuronium and remifentanil. The primary outcome is the QoR-15 score at postoperative day 1. Secondary outcomes include intraoperative hemodynamic parameters, anesthesia recovery indicators, postoperative VAS pain scores, opioid consumption and perioperative adverse events. The study was approved by the Institutional Review Board of The First Affiliated Hospital of Zhengzhou University (approval number: 2023-KY-0137-002). Written informed consent will be obtained from each participant before enrollment.
The First Affiliated Hospital of Zhengzhou University is the lead sponsor of 127 studies on the registry; 74 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients receive ciprofol for anesthesia induction and maintenance. Induction: ciprofol 0.4 mg/kg IV; maintenance: 0.8-2.0 mg/kg/h continuous infusion. All patients receive standardized anesthesia background regimen including dexmedetomidine, sufentanil, rocuronium, remifentanil. Postoperative standardized PCIA is applied.
Drug: Ciprofol
Patients receive remimazolam for anesthesia induction and maintenance. Induction: remimazolam 12 mg/kg/h IV; maintenance: 1-2 mg/kg/h continuous infusion. All patients receive standardized anesthesia background regimen including dexmedetomidine, sufentanil, rocuronium, remifentanil. Postoperative standardized PCIA is applied.
Drug: Remimazolam
Patients receive propofol for anesthesia induction and maintenance. Induction: propofol 1.5-2.0 mg/kg IV; maintenance: 4-12 mg/kg/h continuous infusion. All patients receive standardized anesthesia background regimen including dexmedetomidine, sufentanil, rocuronium, remifentanil. Postoperative standardized PCIA is applied.
Drug: Propofol
Ciprofol injection, intravenous anesthesia induction and maintenance for laparoscopic colorectal surgery.
Remimazolam injection, intravenous anesthesia induction and maintenance for laparoscopic colorectal surgery.
Propofol injection, intravenous anesthesia induction and maintenance for laparoscopic colorectal surgery.
Postoperative Quality of Recovery Scale-15 (QoR-15) score
QoR-15 consists of 15 items covering 5 domains: pain, physical comfort, emotional state, psychological support, and physical independence. Total score ranges from 0 to 150; higher score indicates better postoperative recovery. Assessed at postoperative day 1.
Time frame: Postoperative day 1
Mean arterial pressure (MAP)
Description: Mean arterial pressure measured during perioperative period
Time frame: Before anesthesia induction, After tracheal intubation, 30 minutes after surgical incision, At the end of surgery, At extubation
Cough Visual Analogue Scale (VAS) pain score
Cough-induced visual analogue scale (VAS) pain scores were assessed at 6 hours, 12 hours, 24 hours, and 48 hours postoperatively. Cumulative opioid consumption was recorded at 24 hours and 48 hours after surgery. The VAS score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Time frame: 6, 12, 24, and 48 hours after surgery
Perioperative adverse events
Incidence of hypotension, bradycardia, postoperative nausea and vomiting, respiratory depression, delayed emergence, postoperative delirium.
Time frame: From anesthesia induction to 48 hours postoperatively
Plan to share: Yes — De-identified individual participant data (IPD) including baseline characteristics, intraoperative hemodynamic data, postoperative recovery scores, pain scores and adverse event data will be available upon reasonable request after publication of the primary results. The data will be shared after completion of the study and publication of the main manuscript. Requests should be directed to the principal investigator. Data will be provided after signing a data access agreement.
Ran from Feb 2023 to primary completion in Dec 2024, 22 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Ciprofol · Remimazolam · Propofol
The First Affiliated Hospital of Zhengzhou University →